PBMs are again in the crosshairs of Congress and the FTC. This time, Congress is seeking ways to coordinate with the FTC to enact reforms. It’s becoming increasingly probable that some kind of action will be taken to create a more transparent drug pricing and rebate system.
Subscribe to:
Post Comments (Atom)
< + > AI Is No Longer Optional in Radiology Operations According to GE Healthcare
Healthcare systems are not constrained by lack of technology. They are constrained by staffing shortages, rising demand, and limited capacit...
No comments:
Post a Comment